Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin-backed preferred stocks STRC and SATA show differing price stability amid crypto volatility.

Market News
01 Jul 2026
Crypto Briefing
View Source
Neutral
pluang ai news

Two Bitcoin-backed perpetual preferred stocks, Strategy Inc.'s STRC and Strive Inc.'s SATA, are trading differently amid volatile crypto markets. STRC is stabilizing around $85, below its $100 par value, offering an 11.5%-12% dividend yield with potential upside if it returns to par. SATA trades near par at $97-$98 with a 13% yield and recently shifted to daily dividend payments, unlike STRC's bi-monthly schedule. These differences reflect their Bitcoin reserves and investor risk profiles, important for those considering investment in these unique crypto-linked securities.

More News

Idaho Copper prices $18M public offering, plans NYSE American listing July 2, 2026

Idaho Copper prices $18M public offering, plans NYSE American listing July 2, 2026

Idaho Copper Corporation announced an $18 million public offering of common stock and warrants priced at $4.85 per share, with an additional 45-day option for over-allotments. The proceeds will fund an updated Preliminary Economic Assessment, initial...

Company Fundamentals
Bullish
1 hour ago
Global neonatal infant care market to reach $5.59B by 2035 with 6.21% CAGR driven by rising preterm births.

Global neonatal infant care market to reach $5.59B by 2035 with 6.21% CAGR driven by rising preterm births.

The global neonatal infant care market, valued at $3.06 billion in 2025, is projected to grow to $5.59 billion by 2035 at a CAGR of 6.21%. Growth is driven by increasing preterm births and neonatal complications like respiratory disorders and jaundic...

Market News
Neutral
1 hour ago
FDA approves Casgevy gene therapy for children 2+ with sickle cell disease and beta thalassemia

FDA approves Casgevy gene therapy for children 2+ with sickle cell disease and beta thalassemia

The FDA has approved Casgevy, a gene therapy using CRISPR technology, for children aged 2 and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). This therapy modifies patients' own stem cells to increase fetal hemo...

Market News
Neutral
2 hours ago
Guggenheim announces July 2026 distributions for several closed-end funds, payable July 31.

Guggenheim announces July 2026 distributions for several closed-end funds, payable July 31.

Guggenheim Investments declared distributions for multiple closed-end funds, including Advent Convertible Income Fund and Guggenheim Strategic Opportunities Fund, with payments scheduled for July 31, 2026. These distributions may include income, capi...

Company Fundamentals
Neutral
4 hours ago
AI/R Avenue Code earns Google Gemini Enterprise competency, boosting secure AI adoption in businesses.

AI/R Avenue Code earns Google Gemini Enterprise competency, boosting secure AI adoption in businesses.

AI/R Avenue Code, a subsidiary of AI/R, has achieved Google's Gemini Enterprise competency, recognizing its expertise in deploying advanced AI solutions securely in enterprises. This certification highlights their strengths in security, workflow auto...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App